EMC Capital Management Has $145,000 Stock Position in Select Medical Holdings Co. (NYSE:SEM)

EMC Capital Management lessened its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 38.8% during the 4th quarter, HoldingsChannel reports. The fund owned 7,674 shares of the health services provider’s stock after selling 4,862 shares during the period. EMC Capital Management’s holdings in Select Medical were worth $145,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Geode Capital Management LLC lifted its position in Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after buying an additional 46,880 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Select Medical by 6.7% during the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after acquiring an additional 147,032 shares in the last quarter. Point72 Asset Management L.P. boosted its position in Select Medical by 144.2% during the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Select Medical by 1.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock valued at $57,407,000 after purchasing an additional 24,439 shares in the last quarter. Finally, Victory Capital Management Inc. increased its position in Select Medical by 0.6% in the 3rd quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock worth $41,184,000 after purchasing an additional 7,372 shares during the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Performance

Shares of SEM opened at $19.82 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a one year low of $18.02 and a one year high of $40.98. The company’s fifty day moving average price is $20.61 and its 200 day moving average price is $30.16. The company has a market capitalization of $2.57 billion, a PE ratio of 9.26, a price-to-earnings-growth ratio of 0.66 and a beta of 1.45.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.46 EPS. As a group, analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current year.

Insiders Place Their Bets

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares of the company’s stock, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 19.14% of the company’s stock.

Analysts Set New Price Targets

SEM has been the subject of several recent research reports. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. UBS Group dropped their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Monday. Finally, Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $39.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.